Sakura Finetek and Hamamatsu Photonics Partner to Advance End-to-End Digital Pathology Workflows
The global alliance aims to reduce slide rework and scanning delays by aligning high-quality slide preparation with whole slide imaging.
The global alliance aims to reduce slide rework and scanning delays by aligning high-quality slide preparation with whole slide imaging.
As the 2026 ADA Standards of Care emphasize earlier identification and more precise classification of diabetes, clinical laboratories are rethinking workflows, assay menus, and their role in detection.
Siemens Healthineers has introduced two new blood-based tau assays for research use on the Atellica platform, expanding its brain health portfolio with tests aimed at advancing neurodegenerative disease research.
The Vizient Innovative Technology Program evaluates products submitted through client-led councils for their potential to improve clinical care, patient safety, and business operations.
The new funding brings the initiative's total to $150 million and will focus on tau pathology, multi-marker panels, and AI-driven diagnostics.